Report : Middle East and Africa Urinalysis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Consumables and Instruments), Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis), Application (Disease Screening, and Pregnancy and Fertility), and End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories, and Institutes)
Hospitals and Clinics Urinalysis Segment to Dominate MEA Urinalysis Market during 2020–2028
According to a new market research study on “MEA Urinalysis Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Test Type, Application, End User” is expected to reach US$ 239.74 million by 2028 from 186.27 US$ million in 2021. The market is estimated to grow at a CAGR of 3.7% from 2021 to 2028. The report provides trends prevailing in the MEA urinalysis market along with the drivers and restraints pertaining to the market growth Rising cases of age-related diseases is the major factor driving the growth of the MEA urinalysis market. However, issues associated with stringent regulatory requirements and product recalls hinders the growth of the MEA urinalysis market.
MEA urinalysis market is segmented into product, test type, application, end user, and country. Based on product, the MEA urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021. The MEA urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021. Based on application, the MEA urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The MEA urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021. Based on country, the MEA urinalysis market is segmented into Saudi Arabia, South Africa, UAE, and rest of MEA. South Africa held the largest market share in 2021.
Lockdowns imposed during the COVID-19 pandemic caused people to delay health checkups, which resulted in reduction in the number of tests performed. Also, the market suffered losses due to limited production, supply chain facilities, and business shutdown. The pandemic affected the business operations of the various key urinalysis market players. According to National Kidney Foundation, patients hospitalized for the treatment of COVID-19 are at significant risk of acute kidney injury that can cause severe illness and death. The recovered patients need to be under continuous medical observation, while the patients having blood or protein in their urine should also be monitored as they are also at a high risk of developing chronic kidney diseases. The pandemic has also impacted the regulatory environment and practices, as governments and healthcare providers face considerable challenges to meet the market demand due to increasing cases. However, the continuation of procedures can be seen as countries gradually ease their restrictions and regulatory authorities speed up approval of diagnostic products helping the market grow.
Abbott; ACON Laboratories, Inc.; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc; F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; and Sysmex Corporation are among the leading companies in the MEA urinalysis market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com